annual net income:
-$372.18M+$71.86M(+16.18%)Summary
- As of today (June 17, 2025), IOVA annual net profit is -$372.18 million, with the most recent change of +$71.86 million (+16.18%) on December 31, 2024.
- During the last 3 years, IOVA annual net income has fallen by -$29.93 million (-8.74%).
- IOVA annual net income is now -2355450.63% below its all-time high of -$15.80 thousand, reached on December 31, 2009.
Performance
IOVA Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
-$116.16M-$37.60M(-47.87%)Summary
- As of today (June 17, 2025), IOVA quarterly net profit is -$116.16 million, with the most recent change of -$37.60 million (-47.87%) on March 31, 2025.
- Over the past year, IOVA quarterly net income has dropped by -$3.19 million (-2.82%).
- IOVA quarterly net income is now -3451.31% below its all-time high of $3.47 million, reached on December 31, 2012.
Performance
IOVA quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
-$375.36M-$3.19M(-0.86%)Summary
- As of today (June 17, 2025), IOVA TTM net profit is -$375.36 million, with the most recent change of -$3.19 million (-0.86%) on March 31, 2025.
- Over the past year, IOVA TTM net income has increased by +$74.28 million (+16.52%).
- IOVA TTM net income is now -26562.04% below its all-time high of $1.42 million, reached on March 31, 2013.
Performance
IOVA TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
IOVA Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.2% | -2.8% | +16.5% |
| 3 y3 years | -8.7% | -26.8% | -4.7% |
| 5 y5 years | -88.4% | -66.9% | -63.1% |
IOVA Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -8.7% | +16.2% | -47.9% | +0.2% | -4.7% | +16.5% |
| 5 y | 5-year | -88.4% | +16.2% | -98.3% | +0.2% | -63.1% | +16.5% |
| alltime | all time | <-9999.0% | +16.2% | -3451.3% | +0.2% | <-9999.0% | +16.5% |
IOVA Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$116.16M(+47.9%) | -$375.36M(+0.9%) |
| Dec 2024 | -$372.18M(-16.2%) | -$78.56M(-6.0%) | -$372.18M(-9.2%) |
| Sep 2024 | - | -$83.54M(-14.0%) | -$410.00M(-6.9%) |
| Jun 2024 | - | -$97.10M(-14.1%) | -$440.22M(-2.1%) |
| Mar 2024 | - | -$112.98M(-2.9%) | -$449.64M(+1.3%) |
| Dec 2023 | -$444.04M(+12.2%) | -$116.38M(+2.3%) | -$444.04M(+2.6%) |
| Sep 2023 | - | -$113.76M(+6.8%) | -$432.98M(+3.4%) |
| Jun 2023 | - | -$106.53M(-0.8%) | -$418.83M(+1.7%) |
| Mar 2023 | - | -$107.37M(+1.9%) | -$411.66M(+4.0%) |
| Dec 2022 | -$395.89M(+15.7%) | -$105.32M(+5.7%) | -$395.89M(+1.5%) |
| Sep 2022 | - | -$99.62M(+0.3%) | -$389.90M(+3.6%) |
| Jun 2022 | - | -$99.35M(+8.5%) | -$376.41M(+5.0%) |
| Mar 2022 | - | -$91.61M(-7.8%) | -$358.41M(+4.7%) |
| Dec 2021 | -$342.25M(+31.8%) | -$99.33M(+15.3%) | -$342.25M(+9.9%) |
| Sep 2021 | - | -$86.12M(+5.9%) | -$311.32M(+9.7%) |
| Jun 2021 | - | -$81.35M(+7.8%) | -$283.77M(+6.9%) |
| Mar 2021 | - | -$75.45M(+10.3%) | -$265.44M(+2.3%) |
| Dec 2020 | -$259.58M(+31.4%) | -$68.40M(+16.8%) | -$259.58M(+1.9%) |
| Sep 2020 | - | -$58.57M(-7.1%) | -$254.75M(+3.7%) |
| Jun 2020 | - | -$63.02M(-9.5%) | -$245.67M(+6.7%) |
| Mar 2020 | - | -$69.59M(+9.5%) | -$230.20M(+16.5%) |
| Dec 2019 | -$197.56M(+59.9%) | -$63.57M(+28.5%) | -$197.56M(+18.6%) |
| Sep 2019 | - | -$49.49M(+4.1%) | -$166.56M(+10.4%) |
| Jun 2019 | - | -$47.55M(+28.7%) | -$150.91M(+12.6%) |
| Mar 2019 | - | -$36.95M(+13.4%) | -$134.01M(+8.4%) |
| Dec 2018 | -$123.58M(+34.2%) | -$32.58M(-3.7%) | -$123.58M(+5.8%) |
| Sep 2018 | - | -$33.83M(+10.3%) | -$116.86M(+11.1%) |
| Jun 2018 | - | -$30.66M(+15.6%) | -$105.18M(+7.4%) |
| Mar 2018 | - | -$26.52M(+2.6%) | -$97.89M(+6.3%) |
| Dec 2017 | -$92.06M(+74.1%) | -$25.85M(+16.7%) | -$92.06M(+12.4%) |
| Sep 2017 | - | -$22.15M(-5.3%) | -$81.90M(+4.3%) |
| Jun 2017 | - | -$23.38M(+13.0%) | -$78.51M(+17.7%) |
| Mar 2017 | - | -$20.68M(+31.8%) | -$66.69M(+26.1%) |
| Dec 2016 | -$52.89M | -$15.69M(-16.4%) | -$52.89M(+16.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | -$18.76M(+62.2%) | -$45.56M(+32.3%) |
| Jun 2016 | - | -$11.56M(+68.0%) | -$34.44M(+17.8%) |
| Mar 2016 | - | -$6.88M(-17.7%) | -$29.25M(+5.7%) |
| Dec 2015 | -$27.66M(+129.8%) | -$8.36M(+9.5%) | -$27.66M(+14.5%) |
| Sep 2015 | - | -$7.63M(+19.9%) | -$24.17M(+25.0%) |
| Jun 2015 | - | -$6.37M(+20.2%) | -$19.33M(+28.2%) |
| Mar 2015 | - | -$5.30M(+8.9%) | -$15.07M(+25.2%) |
| Dec 2014 | -$12.04M(-52.6%) | -$4.87M(+73.9%) | -$12.03M(-35.5%) |
| Sep 2014 | - | -$2.80M(+32.6%) | -$18.66M(-26.2%) |
| Jun 2014 | - | -$2.11M(-6.6%) | -$25.28M(-5.0%) |
| Mar 2014 | - | -$2.26M(-80.3%) | -$26.60M(+4.8%) |
| Dec 2013 | -$25.38M(+667.4%) | -$11.50M(+22.2%) | -$25.38M(+143.6%) |
| Sep 2013 | - | -$9.41M(+174.4%) | -$10.42M(+518.9%) |
| Jun 2013 | - | -$3.43M(+227.7%) | -$1.68M(-218.7%) |
| Mar 2013 | - | -$1.05M(-130.2%) | $1.42M(-142.9%) |
| Dec 2012 | -$3.31M(-87.1%) | $3.47M(-614.3%) | -$3.31M(-78.1%) |
| Sep 2012 | - | -$673.90K(+105.9%) | -$15.13M(-25.4%) |
| Jun 2012 | - | -$327.30K(-94.3%) | -$20.27M(-34.4%) |
| Mar 2012 | - | -$5.77M(-30.9%) | -$30.90M(+20.3%) |
| Dec 2011 | -$25.69M(+1497.9%) | -$8.35M(+43.5%) | -$25.69M(+42.1%) |
| Sep 2011 | - | -$5.82M(-46.9%) | -$18.08M(+39.3%) |
| Jun 2011 | - | -$10.96M(+1842.2%) | -$12.98M(+516.7%) |
| Mar 2011 | - | -$564.30K(-23.9%) | -$2.10M(+30.9%) |
| Dec 2010 | -$1.61M(>+9900.0%) | -$741.90K(+3.9%) | -$1.61M(+85.2%) |
| Sep 2010 | - | -$713.80K(+743.7%) | -$868.40K(+449.3%) |
| Jun 2010 | - | -$84.60K(+25.0%) | -$158.10K(+105.9%) |
| Mar 2010 | - | -$67.70K(+2843.5%) | -$76.80K(+389.2%) |
| Dec 2009 | -$15.80K(-72.3%) | -$2300.00(-34.3%) | -$15.70K(-43.3%) |
| Sep 2009 | - | -$3500.00(+6.1%) | -$27.70K(+3.7%) |
| Jun 2009 | - | -$3300.00(-50.0%) | -$26.70K(-30.5%) |
| Mar 2009 | - | -$6600.00(-53.8%) | -$38.40K(-32.7%) |
| Dec 2008 | -$57.10K | -$14.30K(+472.0%) | -$57.10K(+33.4%) |
| Sep 2008 | - | -$2500.00(-83.3%) | -$42.80K(+6.2%) |
| Jun 2008 | - | -$15.00K(-40.7%) | -$40.30K(+59.3%) |
| Mar 2008 | - | -$25.30K | -$25.30K |
FAQ
- What is Iovance Biotherapeutics annual net profit?
- What is the all time high annual net income for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics annual net income year-on-year change?
- What is Iovance Biotherapeutics quarterly net profit?
- What is the all time high quarterly net income for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics quarterly net income year-on-year change?
- What is Iovance Biotherapeutics TTM net profit?
- What is the all time high TTM net income for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics TTM net income year-on-year change?
What is Iovance Biotherapeutics annual net profit?
The current annual net income of IOVA is -$372.18M
What is the all time high annual net income for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high annual net profit is -$15.80K
What is Iovance Biotherapeutics annual net income year-on-year change?
Over the past year, IOVA annual net profit has changed by +$71.86M (+16.18%)
What is Iovance Biotherapeutics quarterly net profit?
The current quarterly net income of IOVA is -$116.16M
What is the all time high quarterly net income for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high quarterly net profit is $3.47M
What is Iovance Biotherapeutics quarterly net income year-on-year change?
Over the past year, IOVA quarterly net profit has changed by -$3.19M (-2.82%)
What is Iovance Biotherapeutics TTM net profit?
The current TTM net income of IOVA is -$375.36M
What is the all time high TTM net income for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high TTM net profit is $1.42M
What is Iovance Biotherapeutics TTM net income year-on-year change?
Over the past year, IOVA TTM net profit has changed by +$74.28M (+16.52%)